We observed that the DC loaded with EpiTCer beads were more potent in enriching and stimulating tumor-specific CD8+ T cells compared to tumor lysate loaded DC, for each of the 1:1–10:1 bead/DC ratios used (Figure 2A). The gene discussed is CD8A; the disease is neoplasm.